IL-1β neutralizing human monoclonal antibodies
Abstract:
The present invention is directed to antigen binding proteins and in particular to IL-1β antigen binding proteins. The present invention further provides compositions comprising the antigen binding proteins, use of the antigen binding proteins and methods for production.
Public/Granted literature
Information query
Patent Agency Ranking
0/0